MedImmune May Sell Itself
MedImmune Inc. (MEDI), the maker of FluMist, revealed that it may be exploring a possible sale sending the stock price soaring $5.79 to close at $43.63.
posted by FC Market News at 2:42 PM
Thursday, April 12, 2007
Previous Posts
- Allen Systems To Buy Mobius
- Marinemax Warns Of Slowing Sales
- Interphase Lowers Outlook
- American Medical Systems Warns
- Fast Track Status For Cell Therapeutics'
- Tractor Supply Reports Higher Revenue
- CheckFree Downgraded
- Citigroup Slashes 17,000 Jobs
- Nuvelo Downgraded
- Cemex Raises Rinker Offer
0 Comments:
Post a Comment
<< Home